Tags

Type your tag names separated by a space and hit enter

[Implantation metastasis at the exit site after percutaneous endoscopic gastrostomy in esophageal carcinoma].
Z Gastroenterol. 1999 Sep; 37(9):789-93.ZG

Abstract

In patients with esophageal cancer causing obstruction percutaneous endoscopic gastrostomy (PEG) is a well-established procedure with a low complication rate to provide sufficient enteral nutrition. We report on a 68-year-old patient suffering from inoperable squamous cell cancer of the proximal esophagus, who underwent PEG insertion prior to a combined radiochemotherapy. Initially bougienage was performed because of subtotal esophageal stenosis. Four months later a metastasis was found at the PEG exit site with involvement of the gastric wall, most likely caused by spread of tumor cells during insertion of the PEG.

Authors+Show Affiliations

Abteilung für Strahlentherapie, Radiologische Universitätsklinik, Universitätskliniken des Saarlandes, Homburg/Saar.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
English Abstract
Journal Article
Review

Language

ger

PubMed ID

10522365

Citation

Deinzer, M, et al. "[Implantation Metastasis at the Exit Site After Percutaneous Endoscopic Gastrostomy in Esophageal Carcinoma]." Zeitschrift Fur Gastroenterologie, vol. 37, no. 9, 1999, pp. 789-93.
Deinzer M, Menges M, Walter K, et al. [Implantation metastasis at the exit site after percutaneous endoscopic gastrostomy in esophageal carcinoma]. Z Gastroenterol. 1999;37(9):789-93.
Deinzer, M., Menges, M., Walter, K., Püschel, W., Braun, A., Niewald, M., Motaref, B., & Schnabel, K. (1999). [Implantation metastasis at the exit site after percutaneous endoscopic gastrostomy in esophageal carcinoma]. Zeitschrift Fur Gastroenterologie, 37(9), 789-93.
Deinzer M, et al. [Implantation Metastasis at the Exit Site After Percutaneous Endoscopic Gastrostomy in Esophageal Carcinoma]. Z Gastroenterol. 1999;37(9):789-93. PubMed PMID: 10522365.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Implantation metastasis at the exit site after percutaneous endoscopic gastrostomy in esophageal carcinoma]. AU - Deinzer,M, AU - Menges,M, AU - Walter,K, AU - Püschel,W, AU - Braun,A, AU - Niewald,M, AU - Motaref,B, AU - Schnabel,K, PY - 1999/10/16/pubmed PY - 1999/10/16/medline PY - 1999/10/16/entrez SP - 789 EP - 93 JF - Zeitschrift fur Gastroenterologie JO - Z Gastroenterol VL - 37 IS - 9 N2 - In patients with esophageal cancer causing obstruction percutaneous endoscopic gastrostomy (PEG) is a well-established procedure with a low complication rate to provide sufficient enteral nutrition. We report on a 68-year-old patient suffering from inoperable squamous cell cancer of the proximal esophagus, who underwent PEG insertion prior to a combined radiochemotherapy. Initially bougienage was performed because of subtotal esophageal stenosis. Four months later a metastasis was found at the PEG exit site with involvement of the gastric wall, most likely caused by spread of tumor cells during insertion of the PEG. SN - 0044-2771 UR - https://www.unboundmedicine.com/medline/citation/10522365/[Implantation_metastasis_at_the_exit_site_after_percutaneous_endoscopic_gastrostomy_in_esophageal_carcinoma]_ L2 - https://medlineplus.gov/esophagealcancer.html DB - PRIME DP - Unbound Medicine ER -